Earnings Releases·Nov 3, 2026, 4:12 PM ET

UFP Technologies — Q3 2026 Earnings Summary

Net sales rose 11.6% year-over-year to $172.4 million for the quarter and 10.3% to $500.6 million for the nine-month period, while net income increased 25.8% to $20.6 million for the quarter and 16.2% to $59.0 million year-to-date.
Adjusted diluted EPS reached $2.88 for the quarter and $8.28 for the nine-month period, supported by gross margin expansion to 29.4% and 29.2% respectively, alongside a reduction in total debt from $135.5 million to $96.0 million.
Management expressed optimism for 2027, citing double-digit growth support at DAS Medical, successful scaling of new programs in the Dominican Republic, and progress on acquisition opportunities, though program transfers and legacy margin improvements remain behind plan.
The company continues to invest in strategic capabilities, including the TPI acquisition for injection molding and expansion at AJR, while actively working to expand its credit facility to fund future high-quality business investments.